Other asset

12 Months Ended

Nov. 30, 2023

14.	Other asset



Cost

Balance as at November 30, 2021, 2022 and 2023	$	19,530

Accumulated amortization

Balance as at November 30, 2021	$	17,089

Amortization		2,441
Balance as at November 30, 2022	$	19,530

Net carrying amounts

November 30, 2023 and November 30, 2022	$	-

May 29, 2018, the Company entered into an agreement with EMD Serono, Inc. (the “Renegotiated Agreement”) to settle all outstanding cash payment obligations stemming from a termination and transfer agreement dated December 13, 2013, as amended (the “2013 Termination Agreement”). The remaining contractual obligations under the 2013 Termination Agreement totalled approxima

tely $28,200, which was comprised of a $4,000 payment due in May 2019 and $24,200 in estimated royalties on future sales of

EGRIFTA

payable over the subsequent four to five years. The Renegotiated Agreement allowed the Company to make one lump sum payment of $23,850 in settlement of the

long-term

obligation of $4,000 and to eliminate all of the royalty payments due on sales of

EGRIFTA

in the United States. The payment made in connection with the settlement of the future royalty obligation has been accounted for as “Other asset” on the consolidated statement of financial position and was amortized through “Cost of sales” on the consolidated statement of net loss.